Hiroto Kishi
Kumamoto, 8628505, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Triphasic mitral inflow velocity in a patient with metastatic lung cancer.
Journal: Journal of echocardiography
Published: January 16, 2024
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Journal: Nature
Published: October 26, 2021
Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia.
Journal: Respiratory investigation
Published: August 29, 2020
Situation and Problems of Activities for Cancer Cooperative Treatment in Kumamoto
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 13, 2019
Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters.
Journal: Biological & pharmaceutical bulletin
Published: January 10, 2018
Pneumothorax in a Patient with Unilateral Pulmonary Artery Agenesis.
Journal: Internal medicine (Tokyo, Japan)
Published: October 17, 2017
Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 05, 2016
Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer.
Journal: Pharmacogenomics
Published: April 03, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026